Entrinsic Bioscience Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
32
- Latest Deal Type
-
M&A
- Investors
-
1
Entrinsic Bioscience General Information
Description
Developer of a bio-mapping and electrophysiology platform designed to discover novel biocatalysts with transformational health benefits. The company's platform harnesses the body's own communication and natural protein regulation system to selectively modulate proteins, enabling patients to get relief from the side effects caused by chemotherapy or radiation therapy.
Contact Information
Website
www.entrinsicbioscience.com(Operating Subsidiary)
Corporate Office
- 500 River Ridge Drive
- Suite 100
- Norwood, MA 02063
- United States
Corporate Office
- 500 River Ridge Drive
- Suite 100
- Norwood, MA 02063
- United States
Entrinsic Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 04-Jun-2024 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series B1) | 07-Jun-2021 | Completed | Generating Revenue | |||
| 10. Debt - General | 30-Apr-2021 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 8. Later Stage VC (Series B1) | 19-Mar-2019 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Mar-2019 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Early Stage VC (Series B) | 04-Mar-2016 | Completed | Startup | |||
| 4. Early Stage VC (Series A) | 31-Jan-2015 | $5.12M | $5.12M | Completed | Startup | |
| 3. Grant | $40M | Completed | Startup |
Entrinsic Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | 7,413,780 | $0.000100 | $0.06 | $0.69 | $0.69 | 1x | $0.69 | 10.73% |
Entrinsic Bioscience Comparisons
Industry
Financing
Details
Entrinsic Bioscience Competitors (42)
One of Entrinsic Bioscience’s 42 competitors is Orbus Therapeutics, a Venture Capital-Backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Orbus Therapeutics | Venture Capital-Backed | Menlo Park, CA | ||||
| Selecta Biosciences | Formerly VC-backed | Watertown, MA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| 4D pharma | Corporation | Leeds, United Kingdom | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA |
Entrinsic Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Entrinsic Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Entrinsic Bioscience Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enterade Investment Partners | Venture Capital | Minority | ||
| Institute for Commercialization of Florida Technology | Not-For-Profit Venture Capital | Minority | ||
| Johnson & Johnson | Corporation | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Junonia Capital, LLC | Corporation | Minority |
Entrinsic Bioscience FAQs
-
When was Entrinsic Bioscience founded?
Entrinsic Bioscience was founded in 2011.
-
Where is Entrinsic Bioscience headquartered?
Entrinsic Bioscience is headquartered in Norwood, MA.
-
What is the size of Entrinsic Bioscience?
Entrinsic Bioscience has 32 total employees.
-
What industry is Entrinsic Bioscience in?
Entrinsic Bioscience’s primary industry is Drug Discovery.
-
Is Entrinsic Bioscience a private or public company?
Entrinsic Bioscience is a Private company.
-
What is Entrinsic Bioscience’s current revenue?
The current revenue for Entrinsic Bioscience is .
-
How much funding has Entrinsic Bioscience raised over time?
Entrinsic Bioscience has raised $122M.
-
Who are Entrinsic Bioscience’s investors?
Enterade Investment Partners, Institute for Commercialization of Florida Technology, Johnson & Johnson, Johnson & Johnson JJDC, and Junonia Capital, LLC are 5 of 9 investors who have invested in Entrinsic Bioscience.
-
Who are Entrinsic Bioscience’s competitors?
Orbus Therapeutics, Selecta Biosciences, Inovio Pharmaceuticals, 4D pharma, and NGM Biopharmaceuticals are some of the 42 competitors of Entrinsic Bioscience.
-
When was Entrinsic Bioscience acquired?
Entrinsic Bioscience was acquired on 04-Jun-2024.
-
Who acquired Entrinsic Bioscience?
Entrinsic Bioscience was acquired by AmiLyfe Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
